Aj. Levine et al., The methylenetetrahydrofolate reductase 677C -> T polymorphism and distal colorectal adenoma risk, CANC EPID B, 9(7), 2000, pp. 657-663
A common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) ge
ne, where a cytosine at nucleotide 677 is replaced by a thymine (677C-->T),
is associated with enzyme thermolability and a reduction in the conversion
of 5,10-methyltetrahydrofolate (5,10-MTHF) into 5-methyltetrahydrofolate.
We assessed the association between homozygosity for the MTHFR 677CT genoty
pe (TT) and colorectal adenoma risk in a large sigmoidoscopy-based case-con
trol study of members of a prepaid health plan in Los Angeles, MTHFR genoty
pe was determined for 471 cases and 510 age-, sex-, clinic-, and sigmoidosc
opy-date-matched controls. Information on RBC and plasma folate levels were
analyzed for 331 cases and 350 controls. When compared with the presence o
f at least one wild-type allele (CT/CC), the odds ratio (OR) for the TT gen
otype was 1.19 [95% confidence interval (CI), 0.77-1.76] after adjusting fo
r race and the matching factors. Compared with those in the lowest quartile
s of RBC and plasma folate and a wild-type allele, adenoma risk was increas
ed for TT homozygotes in the lowest folate quartiles (genotype: OR, 2.04 an
d 95% CI, 0.6-7.0; OR, 1.84 and 95% CI, 0.6-7.0 for RBCs and plasma folate,
respectively) and decreased in TT homozygotes in the highest quartiles (ge
notype: OR, 0.82 and 95% CI, 0.32-2.10; OR, 0.65 and 95% CI, 0.22-1.95, res
pectively), There was also a significant interaction between TT genotype an
d the increased adenoma risk associated with alcohol. These data are consis
tent with an interaction between MTHFR genotype and folate availability.